← FDA Drug Approvals (Drugs@FDA)

IBUPROFEN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA LTD · Approved 2018-02-16

Drug application

FDA Application #

ANDA209178

Application type

Abbreviated New Drug Application (Generic)

Brand name

IBUPROFEN

Generic name

IBUPROFEN ORAL

Active ingredients

IBUPROFEN

Dosage form

SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

AUROBINDO PHARMA LTD

Manufacturer

Aurobindo Pharma Limited

First approval

2018-02-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown